Scalding Antibiotic Silver Sulfadiazine Anti-Inflammatory Silver Sulfadiazine
Product Description
Product Details
| Product Name |
Tacrolimus |
| Appearance |
Tacrolimus Powder |
| Assay |
>99% |
| MW |
804.031 |
| MF |
C44H69NO12 |
| Melting point |
113-115c |
| Boiling point |
871.7C |
Tacrolimus is an immunosuppressant primarily used for preventing and treating rejection reactions after organ transplantation. It inhibits T cell activity, regulates immune system responses, reduces immune attacks, promotes organ survival, and alleviates post transplant symptoms such as pain and swelling.
One of the key roles of Tacolimus after transplantation is to maintain the stability of the graft. After transplantation, patients need to take this medication for a long time to prevent the graft from being harmed by rejection reactions. Tacrolimus can help delay the time of graft failure and improve the survival rate of transplants. By suppressing the immune system, Tacolimus reduced the immune response after transplantation and protected new organs from damage.
Application&Function
treatment effect
Relieve symptoms: Patients with atopic dermatitis often exhibit symptoms such as dry skin, itching, redness, swelling, and blistering. Tacrolimus can effectively alleviate the itching and inflammation symptoms of atopic dermatitis patients, and relieve discomfort such as skin redness, swelling, and itching. It can also exert sedative and anti itch effects by blocking nerve conduction and reducing vascular dilation, significantly reducing patients' itching sensation.
Long term relief: Compared with some traditional therapies, tacrolimus can alleviate symptoms of atopic dermatitis in the short term and help patients maintain a longer period of relief under long-term use. A clinical trial showed that patients with moderate to severe atopic dermatitis treated with tacrolimus showed significant improvement in skin lesion symptoms after 12 weeks of treatment, with long-lasting efficacy.
Safety advantage: Compared with steroid drugs, tacrolimus does not cause side effects such as skin atrophy and pigmentation, making it suitable for long-term use and patients who require repeated treatment. It can be used for patients with moderate to severe atopic dermatitis due to potential hazards, insufficient response to traditional therapies, or inability to tolerate traditional therapies, as a short-term or intermittent long-term treatment, expanding the treatment options for atopic dermatitis.
Specification
){kind=link}